MHR
AHCO icon

Matthew Hamilton Rosenberg’s AdaptHealth AHCO Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$15 – 853
2023
Q4 		$15 Hold
2
– – ﹤0.01% 915
2023
Q3 		$18 Hold
2
– – ﹤0.01% 931
2023
Q2 		$24 Buy
+2
New +$22 ﹤0.01% 954

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Matthew Hamilton Rosenberg's AHCO Position: Q1 2024 in Review

Matthew Hamilton Rosenberg sold out of AdaptHealth (AHCO) in Q1 2024, closing a stake of 2 shares — an estimated $15 sold.

Matthew Hamilton Rosenberg first reported a position in AHCO in Q2 2023 and held it in 3 quarters. The position peaked at $24 in Q2 2023. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

  • Matthew Hamilton Rosenberg reported no remaining AdaptHealth position as of Q1 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 2 AdaptHealth shares in Q1 2024, an estimated $15.
  • Matthew Hamilton Rosenberg first reported a position in AdaptHealth in Q2 2023 and held it in 3 quarters.
  • Matthew Hamilton Rosenberg's AdaptHealth position peaked at $24 in Q2 2023.
  • 210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2024, filed 22 Apr 2024.